Systemic and microvascular comparison of Lactated Ringer’s solution, VIR-HBOC, and alpha-alpha crosslinked haemoglobin-based oxygen carrier in a rat 10% topload model
Source abstract
Abstract
Medical support for traumatic haemorrhage is lacking for far-forward combat units. VIR-HBOC (haemoglobin-based oxygen carrier) is a novel biological therapeutic under development as a field-stable resuscitation fluid. HBOCs have a long history of complications, chief among them is vasoconstrictive hypertension, which must be resolved before efficacy testing. As such, VIR-HBOC was compared against Lactated Ringers (LRS; vehicle) and a cross-linked haemoglobin (ααHb; a known vasoactive HBOC) in a rat topload model. Twenty-three male, Sprague Dawley rats were randomly assigned to receive a 10% infusion (estimated total blood volume) of one test article while normotensive and under anaesthesia. Cardiovascular, blood chemistry and oximetry, microvascular arteriolar diameters, and interstitial tissue oxygenation parameters were measured. Circulatory half-life was calculated by plasma total haemoglobin. Treatment with ααHb caused immediate increases in mean arterial pressure compared to LRS and VIR-HBOC groups, and corresponding arteriolar vasoconstriction (p < .05), which did not occur for LRS or VIR-HBOC. Circulatory half-lives for VIR-HBOC and ααHb were calculated as 340 and 157 min, respectively. This first report of VIR-HBOC showed no evidence of a hypertensive or vasoactive effect. It was well-tolerated over the eight-hour time course of this topload model, which warrants further investigation in studies of haemorrhagic shock.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Trauma, Hemostasis, Coagulopathy, Resuscitation · Traumatic Brain Injury and Neurovascular Disturbances
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Song Biotechnologies LLC
VirTech Bio Inc
Funding
SOCOM
References (44)
Show source-provided references
1. 10.1016/S1072-7515(02)01704-010.1016/S1072-7515(02)01704-0 ↗
2. 10.4244/EIJV4I1A2610.4244/EIJV4I1A26 ↗
3. 10.1021/cr970143c10.1021/cr970143c ↗
4. 10.1001/jama.299.19.jrv8000710.1001/jama.299.19.jrv80007 ↗
5. Golub RM. Hemoglobin-based blood substitutes and risk of myocardial infarction and death. letters section. JAMA: J Am Med Assoc. 2008;300(11):5.
6. 10.1590/S1807-5932200900080001610.1590/S1807-59322009000800016 ↗
7. Schultz SC, Grady B, Cole F, et al. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med. 1993;122(3):301–308.
8. 10.1152/jappl.1994.77.5.234810.1152/jappl.1994.77.5.2348 ↗
9. 10.1007/s00268990018310.1007/s002689900183 ↗
10. 10.1038/nbt0798-67210.1038/nbt0798-672 ↗
11. 10.1152/ajpheart.00972.200110.1152/ajpheart.00972.2001 ↗
12. 10.1152/japplphysiol.00191.200210.1152/japplphysiol.00191.2002 ↗
13. 10.1016/j.freeradbiomed.2003.11.03010.1016/j.freeradbiomed.2003.11.030 ↗
14. 10.1097/TA.0b013e318058245e10.1097/TA.0b013e318058245e ↗
15. 10.1007/BF0302253310.1007/BF03022533 ↗
16. 10.1080/1073119060058022310.1080/10731190600580223 ↗
17. Light W, Malavalli A, Vandegriff K, et al. Liver preservation with machine perfusion and a new human-derived hemoglobin-based oxygen carrier solution (HDHBOC). Philidelphia (PA): American Transplant Congress; 2018.
18. Light W, Malavalli A, Vandegriff K, et al. Development of a new hemoglobin-based oxygen carrier solution (VIR-XV1) for liver allograft preservation in combination with machine perfusion Int Symposium Blood Substitutes & Oxygen Therapeutics Meeting; Montreal, Canada2017.
19. 10.7205/MILMED-D-12-0040810.7205/MILMED-D-12-00408 ↗
20. 10.1016/j.mvr.2014.07.00510.1016/j.mvr.2014.07.005 ↗
21. Sheppard FR, Macko AR, Song BK, RA. Evaluation of third generation Hemoglobin-Based Oxygen Carriers (HBOCs) on systemic and microcirculatory vasoactivity in a top-load rat model. Namru-SA Dtic. 2013:33.
22. Macko AR, Sheppard FR, Song BK, RA. Evaluation of novel perfluorocarbon-based oxygen carriers (PFCs) on systemic and microcirculatory vasoactivity in a top-load rat model. Namru-SA Dtic. 2013:15.
23. 10.1081/BIO-10000125310.1081/BIO-100001253 ↗
24. Nugent WH, Cestero RF, Ward K, et al. Effects of sanguinate(R) on systemic and microcirculatory variables in a model of prolonged hemorrhagic shock. Shock. 2017;52(1S Suppl 1):108–115.
25. 10.1080/21691401.2018.154319710.1080/21691401.2018.1543197 ↗
26. 10.1097/SHK.000000000000108210.1097/SHK.0000000000001082 ↗
27. 10.1016/j.mvr.2015.12.00710.1016/j.mvr.2015.12.007 ↗
28. 10.1016/0026-2862(73)90055-110.1016/0026-2862(73)90055-1 ↗
29. 10.1016/S0026-2862(03)00061-X10.1016/S0026-2862(03)00061-X ↗
30. 10.1111/j.1537-2995.2006.00858.x10.1111/j.1537-2995.2006.00858.x ↗
31. 10.1097/CCM.0b013e3181a0059710.1097/CCM.0b013e3181a00597 ↗
32. 10.1016/S0891-5849(00)00383-X10.1016/S0891-5849(00)00383-X ↗
33. 10.1111/j.1440-1681.2007.04864.x10.1111/j.1440-1681.2007.04864.x ↗
34. 10.1152/japplphysiol.01004.201810.1152/japplphysiol.01004.2018 ↗
35. 10.1152/ajpheart.00626.201010.1152/ajpheart.00626.2010 ↗
36. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med. 1985;26(1):72–76.
37. 10.1046/j.1365-3148.2000.00225.x10.1046/j.1365-3148.2000.00225.x ↗
38. 10.1152/ajpheart.2000.279.6.H313110.1152/ajpheart.2000.279.6.H3131 ↗
39. 10.1152/ajprenal.00513.201910.1152/ajprenal.00513.2019 ↗
40. 10.1152/ajpheart.00303.200810.1152/ajpheart.00303.2008 ↗
41. 10.1152/ajpheart.2000.279.3.H90810.1152/ajpheart.2000.279.3.H908 ↗
42. 10.1038/nrd130710.1038/nrd1307 ↗
43. 10.1073/pnas.88.8.332910.1073/pnas.88.8.3329 ↗
44. 10.1097/EJA.000000000000043610.1097/EJA.0000000000000436 ↗